Melody joined NeoGenomics in December of 2022. Prior to that, she served as President and Chief Operating Officer at SomaLogic. She oversaw life sciences markets, healthcare markets, marketing and product, operations, technology, legal, and HR. Melody assisted the CEO in day-to-day management of the company both internally and externally, with full P&L responsibility.
Prior to SomaLogic, Melody held executive positions in the healthcare space for Qualcomm Life (the healthcare division of Qualcomm) and HealthyCircles, a technology spinoff from Microsoft that she and her team successfully sold to Qualcomm in 2013. At Qualcomm, Melody led corporate deals and M&A transactions and worked extensively across the company in leading the integration efforts of those acquisitions. She has led deals across the healthcare spectrum, including with Merck, TELUS Health Solutions, UnitedHealth Group, Novartis, Surescripts, CVS, and the American Heart Association.
Prior to her time withHealthyCircles, Melody held a variety of other executive, operational, and legal leadership roles, including president of an international consumer-focused brand management firm, and executive vice president of an international software development and consulting firm in the broadcasting space.
Melody has served in multiple community and public roles, including as a trustee of Metropolitan State University of Denver (gubernatorial appointment); director of Stapleton Development Corporation (mayoral appointment); member of two Colorado gubernatorial transition committees; policy advisor to Denver Mayor Michael Hancock and member of his transition team; and energy policy advisor and lead writer of the Bill Ritter for Governor campaign’s New Energy Economy white paper in 2006.
Melody holds a BA (cum laude) in Political Science from the University of Denver and a JD (cum laude) from Harvard Law School.